RUO supplier

Xcel Peptides

Official site and public lab-report archive reviewed

Unclaimed profileReviewed Aug 2, 2026

Supplier documentation profile

Supplier type
Direct RUO catalog
Documentation
Public third-party Janoshik report archive
RUO language
The terms state that products are intended for laboratory in-vitro research purposes only and are not for human or animal use, and the login gate requires a 21+ attestation that products are research-grade materials for laboratory and research purposes only.
Testing claims
The company publishes third-party Janoshik lab reports for selected products in a public archive and states that each production batch is tested before cold storage, with report dates explained in a dedicated blog post.

Observable documentation fields

35/100 public-record coverage

This measures fields in normalized public records. It does not score product quality, sterility, legal compliance, or suitability.

0 normalized reports
ruo Policy10
official Sources10
documentation Access15
public Reports0
identity0
purity0
net Content0
endotoxin0
sterility0
named Laboratory0

Editorial record

Xcel Peptides gates its catalog behind a researcher-verified account with a 21+ age confirmation and researcher-type and license fields, but maintains a public lab-tests archive of third-party Janoshik reports posted as images for specific products including BPC-157/TB-500, Cartalax, and an Ipamorelin/Tesamorelin blend. A company blog post explains that batches of 5,000 to 10,000 vials are tested at production and held in cold storage, so report dates can precede the ship date by months. The contact page lists a Sheridan, Wyoming mailing address while the terms invoke New York governing law. The catalog itself could not be inspected without an account.

Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.

Official sources